Limitations of evidence base for prescribing aripiprazole in maintenance therapy of bipolar disorder
Links shared publicly online about this topic.
- 319total visits
Limitations of evidence base for prescribing aripiprazole in maintenance therapy of bipolar disorder
The evidence base for the prescribing of aripiprazole in maintenance treatment of bipolar disorder is limited to a single trial, sponsored by the manufacturer of aripiprazole, according to a rigorous appraisal of the evidence for its use led jointly by Alexander Tsai of Harvard University, Boston USA, ...
View full resource at medicalxpress.com
Tags: Bipolar Disorder, Bipolar Disorder Medication, Schizophrenia Medication, Antipsychotic Medication, Disease and Condition, Abilify
Most Recently Shared on May 3, 2011 at 9:38 pm By:
Limitations of evidence base for prescribing aripiprazole in maintenance therapy of bipolar disorder http://tw.medicalxpress.com/223663102
Limitations Of The Evidence Base For Prescribing Aripiprazole In Maintenance Therapy Of Bipolar Disorder
medicalnewstoday.com — “The evidence base for the prescribing of aripiprazole in maintenance treatment of bipolar disorder is limited to a single trial, sponsored by the manufacturer of aripiprazole, according to a rigor” View full resource at medicalnewstoday.com
Most Recently Shared on May 3, 2011 at 9:05 pm By:
Limitations Of The Evidence Base For Prescribing Aripiprazole In Maintenance Therapy Of Bipolar Disorder http://mnt.to/3VjX #bipolar
Advertisement
